Top news
Oxford vaccine trial on hold because of potential safety issue
By Erika Edwards & Sara G. Miller
AstraZeneca CEO says participant had neurological symptoms, could be discharged today
By Adam Feuerstein
AstraZeneca shares drop after company announces 'routine' safety pause in coronavirus vaccine trial
By Berkeley Lovelace & Berkeley Lovelace Jr.
All coverage
Inside Oxford's Vaccine Saga: From Wild Hype to Sobering Reality
By Elizabeth Ralph
AstraZeneca Pauses Vaccine Trial for Safety Review
By Katie Thomas & Katherine J. Wu
Oxford Vaccine: AstraZeneca Pauses Trial After Unexplained Illness
By Michelle Cortez & Riley Griffin
Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant
By Elias Visontay
WHO calls delay in AstraZeneca coronavirus vaccine trial a 'wake-up call'
By Noah Higgins-Dunn